Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.

Deckmyn, Olivier; Poynard, Thierry; Bedossa, Pierre; Paradis, Valérie; Peta, Valentina; Pais, Raluca; Ratziu, Vlad; Thabut, Dominique; Brzustowski, Angelique; Gautier, Jean-François

doi:10.3390/biomedicines10030699

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.

Olivier Deckmyn, Thierry Poynard, Pierre Bedossa, Valérie Paradis and 6 more

Olivier Deckmyn

NobleIDNI6P98W50R53S46

Type:Journal Article

Claim Your Authorship

Sign in to see the full record

Creating an account is free.

Create an account

For data access, contact info@nobleid.org.

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19 | NobleID